Connect with us


Pharmacyte Biotech Inc (OTCMKTS:PMCB) Excited With Success In Recent Tests



Pharmacyte Biotech Inc (OTCMKTS:PMCB) is a leading company that has been coming up with outstanding cellular therapies. The company has achieved massive success in this regard because of its inclination to the use of Cell-in-a-Box®, which happens to be a live-cell encapsulation technology. Today the company is pleased to pronounce its manufactured products that were put on trial recently have passed the required tests.

The tests

There were a total of 10 tests conducted, and 7 out of the total have passed. The U.S. Food and Drug Administration (FDA) requires that each batch be subject to the necessary tests. Some of the aspects put to test include “enzymatic activity” and much more.

The Chief Executive Officer of PharmaCyte Kenneth L. Waggoner has expressed his excitement over the results obtained. He says that matters turned out exactly how they expected, and it is a great sign that their products have performed well in the course of the ‘release testing.’

He adds that the passed tests were a sign they were moving in the right direction as accompany.

It is worth noting that the batches manufactured by Austrianova are very important in planning for the future. The tests conducted on these batches will provide useful data. This will be used in the completion of the business giant’s Investigational New Drug application (IND).

Focus on new product

Pharmacyte Biotech says it will be compiling this data with some other information and data under developments. It will eventually submit all this to the FDA in a quest to get approval for a new product.

The new deal the company is thinking about is a clinical trial focused on inoperable pancreatic cancer (LAPC) in its advanced stage.

Austrianova Singapore happens to be this company’s partner, and it is the one entrusted with conducting the release tests. The point of focus is specifically the functionality aspect of the encapsulated cells. Third-party laboratories are going to be tasked with carrying out a series of tests inline be with the safety of the clinical trial product.

PharmaCyte says it is determined on its quest to treat cancer. It has developed a video that it is making accessible to all interested persons. The business guru says that the pancreatic cancer treatment is the way to go for struggling patients.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.